Scholars Central

Conference abstractPublished 12 Nov 2012

5-Lipoxygenase and ADP-Ribose transferase-1 in Alzheimer’s disease: The novel targets for neuroregeneration

Authors: Joanna B. Strosznajder, Grzegorz A. Czapski, Kinga Czubowicz, Robert P. Strosznajder

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

A ntiinflammatory (AI) drugs are considered for the treatment of Alzheimer?s disease (AD). AI drugs could slow the progression or could delay the onset of AD. Our data using AD models showed that inhibition of cyclooxygenases (COXs) and lipoxygenases (LOXs) protects against amyloid beta (Aβ 1-42 ) evoked cognition impairment. Our data indicated that systemic inflammatory response (SIR) significantly modulates Aβ 1-42 toxicity in animal model of AD. SIR induces expression of several prooxidant genes in hippocampus and activates genes for enzymes regulating arachidonic acid release (PLA 2 ) and its metabolism, including 5-LOX and 12/15-LOX. The enhancement of genes expression for members of ADP-ribose tranferases (ART1,3,9,12,14; formerly PARP) family and the stimulation of ART-1 activity was also found. More recent study presented that family of COXs and LOXs, and ART-1, the important regulator of transcription, could be involved in functioning of AD brain via mechanisms different from classical inflammation. These mechanisms include the bioactive molecules generated by activity of these enzymes and by their specific interaction. The last studies presented that these enzymes interact with gamma secretase complexes and regulate Aβ concentration, and/or interact with specific kinases engaged in tau hyperphosphorylation observed in AD. The inhibitors of ART-1 modulate the phosphatidylinositol 3-kinase and glycogen synthase kinase-3-activity. Our data indicated that 5-LOX and ART-1 inhibitors protect hippocampal neurons against death evoked by several molecular and metabolic events occurring in AD (oxidative/nitrosative stress, glucose deprivation, inflammation). We propose that inhibition of 5-LOX and ART-1 could be considered as the novel strategy for neuroregeneration in AD therapy

Subjects

Biology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Cell Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cell Science & Therapy
  • SubjectBiology
  • BylineArticles whose byline prints “Joanna B. Strosznajder”
  • BylineArticles whose byline prints “Grzegorz A. Czapski”
  • BylineArticles whose byline prints “Kinga Czubowicz”
  • BylineArticles whose byline prints “Robert P. Strosznajder”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels